English

cancer-patients / English

Stories published on Nov 26
  • Related stories in the last 90 days
  • Stories published on Nov 26

Wednesday, Nov 26

22

Missing cancer gene explains why some lung tumors respond well to immunotherapy

medicalxpress.com

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in Cell Reports, Mayo Clinic researchers have found several previously unknown genetic and cellular…

High risk of metastatic recurrence found among young cancer patients

medicalxpress.com

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence—a condition associated with significantly worse…

16

Breakthrough Obe-cel drug for aggressive leukaemia to reach NHS patients

A new immunotherapy for a severe form of blood cancer will soon be available on the NHS, offering new hope to adults whose disease has returned or stopped responding to conventional treatment.

Another perk of weight-loss drugs? Fewer colon cancer deaths, a study found

A study of 6,800 colon cancer patients found those who took Ozempic or Mounjaro were more likely to survive the disease. It may boil down to inflammation.

12

‘I was left in agony after cancer surgery – but hospital staff wouldn’t help’

www.independent.co.uk

Exclusive: Patient said she suffered nightmares following stay at under-fire NHS trust criticised by health watchdog over staff shortages

10

SISAQOL-IMI provides guidance for implementing patient-reported outcomes in cancer clinical trials

www.news-medical.net

The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just announced the publication of its pivotal paper in The Lancet Oncology outlining how its…

02

Zanidatamab shows durable and meaningful responses in HER2-positive biliary tract cancer

www.news-medical.net

Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the HERIZON-BTC-01 clinical trial led by…

Advancing patient-reported outcomes in cancer clinical trials

medicalxpress.com

The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how its recommendations for patient-reported…

Tuesday, Nov 25

23

HER2-targeted therapy shows promising results in rare bile duct cancers

medicalxpress.com

Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the HERIZON-BTC-01 clinical trial led by…

20

Scientists develop one-product-fits-all immunotherapy for pancreatic cancer

medicalxpress.com

Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median survival is…

18

The deadly cancer hiding in plain sight — and why most patients never get screened

www.foxnews.com

Researchers reveal that current lung cancer screening guidelines miss 65% of patients, and call for universal age-based screening to catch more cases.

Popular Heart Burn Drugs Linked to Worse Survival in Another Cancer Type

www.medpagetoday.com

(MedPage Today) -- The use of potent aldehyde dehydrogenase 1 A1 (ALDH1A1)-activating proton pump inhibitors (PA-PPIs) was associated with inferior survival outcomes in patients with newly diagnosed glioblastoma, according to a…

Liquid biopsy tool can guide early-stage gastric cancer treatment

medicalxpress.com

Early-stage gastric cancer can be assessed more accurately using a new liquid biopsy tool that predicts lymph node metastasis, as reported by researchers from Science Tokyo. They developed a model that uses deoxyribonucleic acid (DNA)…

New medication offers potential treatment for patients with deadliest form of blood cancer

www.news-medical.net

Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients with the deadliest form of blood cancer.

16

Much-needed new drug approved for deadliest blood cancer

medicalxpress.com

Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients with the deadliest form of blood cancer.

13

Business News | HemeNext 2025: India's Premier Hematology Conference Unveils the Future of Genomics, Transplants and AI in Blood Cancer Treatment

www.latestly.com

Get latest articles and stories on Business at LatestLY. Gurgaon (Haryana) [India], November 25: HemeNext 2025, held at The Westin Hotel, Gurgaon on the 22nd and 23rd of November, welcomed nearly 300 delegates from across the country,…

06

David Cameron's brave prostate cancer story shows we must put 1 thing at centre of care

www.express.co.uk

Britain badly needs to take action on behalf of cancer patients.

04

Focused ultrasound combined with chemotherapy improves survival in glioblastoma patients

www.news-medical.net

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40 percent increase in overall survival in a landmark trial of 34 patients led by…

01

Focused ultrasound with chemotherapy shows survival benefit for brain cancer patients, clinical trial finds

medicalxpress.com

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40% increase in overall survival in a landmark trial of 34 patients led by…